Value proposition

AI for Skin Cancer Detection

We’re working for a world where no one dies from skin cancer by deploying our AI medical device, DERM, to create the world’s most advanced skin cancer pathways.

Skin Analytics are proud to work with NHS dermatology teams to deploy AI powered skin cancer pathways.

Our pathways enable NHS organisations to discharge benign lesions earlier in the pathway and therefore tackle backlog, free up out-patient delays and crucially, reserve limited dermatology capacity to prioritise patients with skin cancer by focusing on providing potentially life-saving treatment.

Some things we’re a little bit proud of:

🚀We’ve deployed with 18 NHS partners across primary and secondary care since 2020

🥇We’re the first and only AI skin cancer pathway within the NHS

✅DERM is the only UKCA approved Class IIa AI as a Medical Device for dermatology

🤯DERM is used in pathways that have seen over 100,000 NHS patients and identified more than 10,000 cancers

💪We’ve helped NHS organisations avoid up to 94% of face-to-face appointments in secondary care

🤳We provide Bupa and Vitality's remote skin assessment service

❤️Everything we do is in pursuit of better patients outcomes that are sustainable for health systems, globally